Education and experience:
Dr Marie L De Bruin is an assistant professor at the division of Pharmacoepidemiology & Clinical Pharmacology. She was trained as a pharmacist and epidemiologist and has combined academic research with working for the regulatory authorities. Her research focusses on developing new tools, standards and approaches to evaluate the efficacy, safety, quality and performance of medical products in order to assess benefit-risk and facilitate a sound and transparent regulatory decision making. Furthermore, she studies the role of pharmacoepidemiology in the drug regulatory setting and pharmacovigilance. The main clinical areas are cardiovascular diseases and cancer.
As of August 2016, Marie L De Bruin has been appointed professor in Regulatory Science at the University of Copenhagen and director of the Copenhagen Institute of Regulatory Science. She will stay involved in the activities of the WHO Collaborating Centre for Pharmaceutical Policy and Regulation, which is hosted at the division of Pharmacoepidemiology & Clinical Pharmacology.
Dr De Bruin is currently supervising 4 PhD students; and she previously supervised 6 other PhD students (since 2012) all of whom have completed.